Last updated: December 4, 2024
Sponsor: University of Pennsylvania
Overall Status: Active - Recruiting
Phase
N/A
Condition
Familial Hypercholesterolemia
Hypercholesterolemia
Treatment
Demographics, diagnosis type, genotype, lipid profile, treatment allocation, country of residence.
Clinical Study ID
NCT04815005
HICC
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Diagnosis of homozygous familial hypercholesterolemia (HoFH) clinically ofgenetically determined
Exclusion
Exclusion Criteria:
- No diagnosis of HoFH
Study Design
Total Participants: 1000
Treatment Group(s): 1
Primary Treatment: Demographics, diagnosis type, genotype, lipid profile, treatment allocation, country of residence.
Phase:
Study Start date:
January 24, 2017
Estimated Completion Date:
December 31, 2025
Study Description
Connect with a study center
Department of Vascular Medicine, Amsterdam UMC
Amsterdam,
NetherlandsActive - Recruiting
Department of Medicine, Division of Lipidology and Hatter Institute for Cardiovascular Research in Africa, University of Cape Town
Cape Town,
South AfricaActive - Recruiting
c. Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of Witwatersrand
Johannesburg,
South AfricaActive - Recruiting
University of Pennsylvania
Philadelphia, Pennsylvania 19104
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.